Transfusion safety system Mirasol®

Reduce the pathogen load in donated blood and inactivate residual white blood cells A proactive approach to improved blood safety No matter where you are located, increased travel, climate change, evolving pathogens, emerging pandemics, and the need to advance healthcare practices have put global blood safety at the forefront of industry focus. With all this change, it’s time to take a proactive approach to protecting patients from the potential dangers of donated blood. The Mirasol™ Pathogen Reduction Technology (PRT) system can help you do that by reducing the pathogen load of a broad range of disease-causing viruses, bacteria, and parasites. The system also inactivates residual white blood cells found in blood components, which may help to reduce transfusion reactions in patients. Powerful, proven, and so much potential The Mirasol PRT system is the only pathogen reduction technology system shown in a human clinical trial to reduce the transfusion-transmitted infection (TTI) of a disease, reducing TTI of malaria by 87%.¹ Powerful, proven, and so much potential The Mirasol PRT system is the only pathogen reduction technology system shown in a human clinical trial to reduce the transfusion-transmitted infection (TTI) of a disease, reducing TTI of malaria by 87%.¹